Results 21 to 30 of about 377,889 (137)
The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients [PDF]
Human Vaccines & ImmunotherapeuticsBackground: Human papillomavirus (HPV) infection remains the most prevalent sexually transmitted viral infection worldwide and a major etiologic factor for cervical and other anogenital cancers.
Dominik Pruski +4 more
doaj +2 more sources
PLoS ONE, 2022 Human papillomavirus (HPV) prevalence and genotype distribution data is important for HPV vaccine monitoring. This study investigated the prevalence and distribution of HPV genotypes in cervical lesions of unvaccinated women referred to Nelson Mandela ...
Zizipho Z A Mbulawa +4 more
doaj +2 more sources
Vaccines, 2022 Human Papillomavirus (HPV) is responsible for epithelial lesions and cancers in both males and females. The latest licensed HPV vaccine is Gardasil-9®, a 9-valent HPV vaccine which is effective not only against the high-risk HPV types, but also against ...
Antonio Di Lorenzo +5 more
doaj +1 more source
PLoS ONE, 2021 As part of the human papillomavirus (HPV) vaccination strategy in South Africa, it is essential to have information on HPV prevalence, and HPV types distribution among the unvaccinated population. Information on the prevalence of HPV and the distribution
Zizipho Z A Mbulawa +3 more
doaj +1 more source
Vaccines, 2023 cSCC (cutaneous squamous cell carcinoma) and its precursors are a major cause of morbidity, especially in immunosuppressed patients, and are frequently associated with human papillomavirus (HPV) infections. The purpose of this study is to investigate the
Simon Bossart +7 more
doaj +1 more source
Vaccines, 2022 Neuromyotonia is a rare peripheral nerve hyperexcitability syndrome often associated with antibodies directed against contactin-associated protein-like 2 and leucine-rich, glioma inactivated 1.
Maryam Hatami +5 more
doaj +1 more source
Updated Efficacy Data –GARDASIL® [PDF]
, 2020 2007 February 22, Eliav Barr, Program Head HPV Vaccines, Merck Research Laboratories presented an update of efficacy findings in the clinical program for Gardasil (quadrivalent HPV vaccine) during the ACIP ...
Barr, Eliav
core +1 more source
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
BMC Health Services Research, 2023 Background Africa has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Gavi, the Vaccine Alliance (Gavi ...
Joël Arthur Kiendrébéogo +8 more
doaj +1 more source
Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer [PDF]
Investigative and Clinical Urology, 2021 Purpose: Nearly half of penile cancers are related to human papillomavirus (HPV) infection. Investigations of tumor- and HPV-specific T cell reactivity in regional lymph nodes (LNs) from patients with penile cancer are warranted.
Lu Zhang +7 more
doaj +1 more source
Vaccines, 2023 Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as ...
Esperança Lourenço Guimarães +13 more
doaj +1 more source